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1136-85 Ischemic Preconditioning Increases Heat Shock 
Protein-72 Protein Expression and Reduces Elevation of 
Creatine Kinase-MB Following Coronary Artery Bypass 
Graft in Humans
Christian Vahlhaus, Joachim Neumann², Tonny D. Tjan³, Frauke Janssen³, Hans H. 
Scheld³, Wilhelm Schmitz², Günter Breithardt, Thomas Wichter, University of Muenster, 
Muenster, Germany
Background: Ischemic preconditioning, ie, the reduction of infarct size development dur-
ing prolonged and severe myocardial ischemia by one or more preceding short episodes
of ischemia and reperfusion, is the most powerful endogenous cardioprotective effect.
We investigated whether a stress activated signal-transduction via heat shock protein 72
(HSP-72) mediated phopshorylation of p38 Mitogen activated protein kinase (MAPK) is
involved in the creatine kinase-MB (CKMB) release reducing effect of ischemic precondi-
tioning in patients undergoing CABG.
Methods: According to the ischemic episodes within 24-48 hours before CABG patients
with angina CCS III or IV were classified as preconditioned (IP, n=9), whereas patients
with angina CCS I or II formed the control group (CON, n=10). The effect of IP on the
CABG induced maximal CKMB-release was examined. Biopsies from ischemic and con-
trol regions in each patient were processed to analyse protein expression of HSP-72 and
the calcium handling proteins phospholamban (PL), sarcoendoplasmic Ca-ATPase 2a
(SERCA), calsequestrin (CSQ), the inhibitory subunit of troponin (TnI) and phosphoryla-
tion of MAPK.
Results: IP reduced CKMB (18.7±1.3 vs. 13.8±1.5 U/L, CON vs. IP, mean±SD, p=0.02).
Results of biopsy specimens are depicted in table 1 (relative changes of *protein expres-
sion and #MAPK-phosphorylation).
Conclusion: Cardioprotection during CABG can be improved with IP. Possible mecha-
nisms are the induced expression of HSP-72 and/or SERCA.
1136-86 Protein Kinase C Epsilon Is Upstream and Protein 
Kinase C Alpha Is Downstream of MitoKATP Channels 
in the Signaling of Ischemic Preconditioning in the 
Human Myocardium
Ashraf Hassouna, Bashir M. Matata, Manuel Galiñanes, University of Leicester, 
Leicester, United Kingdom
Background: PKC is part of the signal transduction of ischemic preconditioning (IPC)
but the PKC isoforms involved and their relation to mitoKATP channels is unclear. Meth-
ods: Right atrial muscles from patients undergoing cardiac surgery were sectioned and
after equilibration were randomized to receive one of the following protocols: aerobic con-
trol (A/C), simulated ischemia for 90 min and reoxygenation for 120 min (SI/R), IPC using
5 min SI/ 5 min R and the following inhibitors were added 10 min before and during IPC:
V1-2 peptide [10 µM], GO6976 [100 nM], Rottlerin [100 µM], and LY333531 [100 nM] for
PKCε, α, δ, β respectively. To investigate the location of the PKC isoforms involved in IPC
in relation to mitoKATP channels, PKC α and ε inhibitors were added 10 min before and
during preconditioning by Diazoxide (DXZ)[100 µM] in a second experiment. CK leakage
and MTT cell viability were measured. Phosphorylation of PKC isoforms were measured
using immunoblots after treatment with IPC or DXZ. Results: In Fig, PKCε and α inhibi-
tors blocked IPC whereas PKCδ and β inhibitor did not. The protection elicited by
mitoKATP channels opening with DXZ was blocked by the inhibition by PKCα but not by
inhibition of PKCε isoforms. The MTT values mirrored the CK results. In addition, DXZ
caused increased phosphorylation of PKCα similar to IPC but failed to cause significant
increase of PKCε phosphorylation. Conclusion: Both PKCε and α are involved in IPC of
the human myocardium with PKCε upstream and PKCα downstream of mitoKATP chan-
nels.
1136-87 Remote Preconditioning by Infrarenal Occlusion of the 
Aorta Protects the Rat Heart From Infarction by a 
Molecular Mechanism Involving Free Radicals and a p38 
Mitogen Activated Protein Kinase Activation
Christof Weinbrenner, Alexander Werschy, Falk Schulze, Ruth H. Strasser, University of 
Technology, Dresden, Germany
Background: Ischemic preconditioning (PC) is a powerful mechanism in reducing the
infarct size of the heart. Protection can be provided either by an ischemic stimulus of the
heart itself (classical or orthotopic PC) or by ischemia of an organ distant to the heart
(remote or heterotopic PC).
Objective and methods: To address the question whether remote PC is dependent on
endogenously released free radicals and/or on an activation of p38 MAPK, infarct size
was determined in an in situ model of infrarenal occlusion of the aorta (IOA) in the rat
after pharmacological inhibition of free radicals or p38 MAPK.
Results: Control hearts (30 min regional ischemia followed by 30 min of reperfusion) had
an infarct size of 50±2%, whereas classical PC with one ischemia/reperfusion cycle (I/R)
reduced it to 21±4% and with three I/R cycles to 14±1% of the risk zone (p<0.001). 15
min IOA followed by a 10 min reperfusion period reduced the infarct size to 20±3%
(p<0.001 vs. control; p=0.051 vs. PC three I/R cycles).
20 mg/kg body weight MPG, a free radical scavenger, completely blocked the protection
obtained by IOA (46±3%, p<0.001 vs. IOA no MPG) as well as the one obtained by clas-
sical PC with one I/R cycle (43±4%, p<0.01 vs. PC one I/R cycle no MPG). Protection of
classical PC with three I/R cycles could, however, not be blocked (13±4%). MPG itself
had no influence on infarct size in control hearts (53±5%).
Using SB203580, a selective p38 MAPK-inhibitor, at a dose of 2 mg/kg body weight, pro-
tection by remote PC was blocked (46±3%, p<0.001 vs. IOA no SB) as well as by classi-
cal PC with three I/R cycles (42±4%, p<0.001 vs. PC no SB). Again SB itself had no
influence on infarct size in control hearts (47±3%).
Conclusion: Protection of the heart by heterotopic PC using IOA is nearly as powerful as
orthotopic preconditioning. Both protection methods share as common elements in their
signal transduction pathways free radicals and p38 MAPK. Since orthotopic PC by one I/
R cycle but not by three I/R cycles could be blocked by MPG, protection by orthotopic PC
is more robust than protection by heterotopic PC. The protecting substances, which are
located upstream of p38 MAPK, could be free radicals but remain to be characterized fur-
ther.
1136-88 The Polymorphisms C (-260) T in the Promoter Region 
of CD14 Receptor Gene and G (-174) C of Interleukin-6 
Gene Are Not Related to the Immune Response to 
Chlamydia Pneumoniae Infection and Heat Shock 
Protein-60 in Ischaemic Heart Disease
Giovanna Di Giannuario, Luigi M. Biasucci, Alessandra Ciervo, Giovanna Liuzzo, Matteo 
Santamaria, Maddalena Piro, Salvatore Brugaletta, Antonio Cassone, Antonio Cassone, 
Pierfranco Pignatti, Filippo Crea, Catholic University, Rome, Italy, Istituto Superiore 
Sanita', Rome, Italy
Background: The conflicting results on the role of Chlamydia pneumoniae (Cp) in
ischaemic heart disease might be related to modulation of individual response to Cp-
infection by genetic polymorphisms. The CD14 membrane receptor is a mediator for
monocyte activation by bacterial products, as lypopolysaccharide and Chlamydial Heat
Shock Protein 60 (HSP60Cp). Interleukin 6 is a pro-inflammatory cytokine stimulating B-
lymphocytes differentiation and antibody production. The aim of this study was to evalu-
ate if two functional genetic polymorphisms, the C (-260) T polymorphism in the promoter
region of the CD14 receptor gene and the G (-174) C polymorphism of interleukin 6
gene, are related to immune response to Cp in patients with IHD. Methods: we studied 51
patients with IHD. In all patients we measured serum levels of Antibody anti-HSP60Cp
(AbHSP60) (ELISA) and IgG anti Cp. The polymorphisms C (-260) T of CD14 receptor
gene and G (-174) C of Interleukin 6 gene were detected by polymerase chain reaction
and restriction analysis. Results: We did not find significant differences in AbHSP60
serum SD) among the C (-260) T polymorphisms of the CD14 receptor ± levels (AU;
mean 0.42, 0.63 ± gene: CC homozygotes, CT heterozygotes, and TT homozygotes
(0.66 0.46, respectively; p=ns). No differences were also found among the ± 0.37, 0.77 ±
three genotypes of G (-174) C Interleukin 6 gene polymorphism: GG homozygotes, 0.37,
± 0.42, 0.58 ± 0.37, 0.74 ± GC heterozygotes and CC homozygotes (0.62 respectively;
p=ns). IgG anti Cp levels (median, range), were not significantly different between the
three genotypes of C (-260) T CD14 receptor gene polymorphism, CC homozygotes, CT
heterozygotes and TT homozygotes (24, 0-128; 48, 0-256; 8, 0-32, respectively; p=ns)
and between the three genotypes of G (-174) C Interleukin 6 gene polymorphism: GG
Gene Hibernating LAD/normal
3 Months 5 Months
Collagen Type I
2.8 ± 0.7* 1.3 ± 0.2†
Collagen Type III 2.2 ± 0.5* 1.4 ±0.2
Collagen Type VI 1.5 ± 0.2* 0.9 ± 0.1†
Fibronectin 4.9 ± 2.7* 1.3 ± 0.2
Vimentin 1.8 ± 0.3* 1.2 ± 0.1†
GAPDH 0.9 ± 0.2 0.9 ± 0.1
*LAD vs. normal p<0.05; mean ± SEM
† 5 vs. 3 Months p< 0.05, Statistical Analysis of Microarray
Table 1: Biopsy specimens
mean±SD PL*  SERCA*  CSQ*  TnI*  HSP-72*  MAPK#
CON 0.24±0.12 -0.26±0.07 -0.09±0.04 -0.12±0.07 0.09±0.12 0.05±0.28
IP 0.06±0.35 0.33±0.19 -0.02±0.07 0.12±0.18 0.44±0.11 0.84±0.43
t-test: P 0.626 0.008 0.354 0.212 0.045 0.141
